๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma

โœ Scribed by Krishnamurti, Uma; Hammers, Jennifer L; Atem, Folefac D; Storto, Patrick D; Silverman, Jan F

Book ID
109887816
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
98 KB
Volume
22
Category
Article
ISSN
0893-3952

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Assessment of HER2 gene status in breast
Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17
โœ Semir Vranic; Bryan Teruya; Susan Repertinger; Pamela Ulmer; Jill Hagenkord; Zor ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 216 KB

## Abstract ## BACKGROUND: The current study was performed to determine the impact of polysomy 17 on the interpretation of __HER2__ testing of invasive breast carcinomas using fluorescent in situ hybridization methods. Current American Society of Clinical Oncology/College of American Pathologists

Prognostic significance of in situ carci
Prognostic significance of in situ carcinoma associated with invasive breast carcinoma : A natural experiment in cancer immunology?
โœ K. N. Naresh; Anita M. Borges ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 54 KB ๐Ÿ‘ 2 views

## Prognostic Significance of In Situ article: ''the greatest impact of IFN-a-2b was manifest early in the first year of treatment . . .''. If further data ## Carcinoma Associated with confirm this trend, it may be possible to shorten the Invasive Breast Carcinoma duration (and diminish the cost)

Prognostic significance of in situ carci
Prognostic significance of in situ carcinoma associated with invasive breast carcinoma: A natural experiment in cancer immunology?
โœ Maurice M. Black; Reinhard E. Zachrau; Benjamin F. Hankey; Eric J. Feuer ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 958 KB

## BACKGROUND. Our previous studies indicate that the in situ phase of mammary carcinogenesis is characteristically associated with cell-mediated immunity (CMI) against an immunogen shared by most breast carcinomas. Such reactivity is inversely correlated with stage and appears to impede in situ-t